Skip to main content

Table 3 Baseline demographic data

From: Correction to: Protocol and baseline data for a prospective open-label explorative randomized singlecenter comparative study to determine the effects of various intravenous iron preparations on markers of oxidative stress and kidney injury in chronic kidney disease (IRON-CKD)

 

Venofer 200

Cosmofer 200

Monofer 200

Monofer 1000

Total group

Age, years (SEM)

52.1 (4.3)

64.2 (2.6)

59.5 (5.0)

59.3 (5.3)

58.8 (2.2)

Male/female, numbers

6/4

6/4

4/6

7/3

23/17

Serum ferritin, μg/L (SEM)

58.5 (11.6)

82.9 (21.8)

64.7 (10.9)

69.1 (18.4)

68.8 (8.0)

Transferrin saturation percentage (SEM)

21.1 (2.9)

25.4 (4.9)

21.2 (3.1)

17.8 (1.7)

21.4 (1.7)

Haemoglobin, g/L (SEM)

122.1 (4.6)

129.6 (7.5)

123.0 (5.5)

115.5 (4.5)

122.6 (2.8)

Serum creatinine, micromole/L (SEM)

279.2 (42.7)

247.6 (39.3)

176.2 (16.8)

235.5 (22.5)

234.6 (16.6)

eGFR, mL/min per 1.73 m2 (SEM)

25.8 (5.1)

26.3 (4.3)

34.8 (4.2)

26.2 (3.9)

28.2 (2.2)

uACR, mg/mmol (SEM)

74.1 (33.1)

26.4 (8.8)

167.0 (110.8)

144.6 (50.5)

107.9 (33.9)

uPCR, mg/mmol (SEM)

105.9 (47.3)

37.7 (12.6)

238.6 (158.3)

206.5 (72.2)

154.2 (48.4)

Serum Albumin g/L (SEM)

36.5 (1.02)

38.0 (1.48)

36.3 (1.56)

35.1 (1.27)

36.5 (0.67)

C-reactive protein, mg/L (SEM)

8.1 (3.3)

5.2 (1.8)

9.7 (4.8)

6.8 (2.6)

7.5 (1.6)